Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Case report

Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation

Authors: Yusuke Sakamaki, Konosuke Konishi, Koichi Hayashi, Akinori Hashiguchi, Matsuhiko Hayashi, Eiji Kubota, Takao Saruta, Hiroshi Itoh

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

The mechanism for the development of thrombotic microangiopathy (TMA) during sepsis has only been partially elucidated. TMA is recognized as a disease caused by various factors, and may be involved in the emergence of organ damage in severe sepsis. Here we report a case of TMA that followed disseminated intravascular coagulation (DIC) due to severe infection in a patient with a reduced ADAMTS-13 activity level.

Case presentation

An 86-year-old Japanese woman was admitted to our hospital because of low back pain and fever. A careful evaluation led to a diagnosis of acute obstructive pyelonephritis due to a ureteral stone. Proteus mirabilis was isolated from both blood and urine cultures. The patient developed systemic inflammatory response syndrome and DIC, and was treated with antibiotics and daily continuous hemodiafiltration. Although infection and the coagulation abnormalities due to DIC were successfully controlled, renal failure persisted and her consciousness level deteriorated progressively in association with severe thrombocytopenia and microangiopathic hemolytic anemia. We therefore suspected the presence of TMA and started plasma exchange, which resulted in an impressive improvement in consciousness as well as the laboratory abnormalities. The ADAMTS-13 activity was 44% and the patient tested negative for the ADAMTS-13 inhibitor prior to the initiation of plasma exchange. A renal biopsy was performed to determine the etiology of acute renal injury, which revealed findings that were interpreted to be compatible with the sequelae of TMA. The follow-up studies performed after the successful treatment of TMA showed that her plasma ADAMTS-13 activity level remained persistently low. It is surmised that septic DIC occurring in the presence of preexisting reduced ADAMTS-13 activity have led to the development of secondary TMA in the present case.

Conclusion

The present case suggests that TMA can be superimposed on sepsis-induced DIC, and plasma exchange is expected to be beneficial in such situations. Clinicians should consider the possibility of secondary TMA that follows sepsis-induced DIC in certain indicative clinical settings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clark WF: Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Semin Dial. 2012, 25 (2): 214-219. 10.1111/j.1525-139X.2011.01035.x.CrossRefPubMed Clark WF: Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Semin Dial. 2012, 25 (2): 214-219. 10.1111/j.1525-139X.2011.01035.x.CrossRefPubMed
2.
go back to reference Park YA, Waldrum MR, Marques MB: Platelet count and Prothrombin time help distinguish thrombotic thrombocytopenic purpura. Hemolytic uremic syndrome from disseminated intravascular coagulation in adults. Am J Clin Pathol. 2010, 133 (3): 460-5. 10.1309/AJCPPNF63FLIORCI.CrossRefPubMed Park YA, Waldrum MR, Marques MB: Platelet count and Prothrombin time help distinguish thrombotic thrombocytopenic purpura. Hemolytic uremic syndrome from disseminated intravascular coagulation in adults. Am J Clin Pathol. 2010, 133 (3): 460-5. 10.1309/AJCPPNF63FLIORCI.CrossRefPubMed
3.
go back to reference Taylor FB, Toh CH, Hoots WK, Wada H, Levi M: Scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and haemostasis (ISTH). towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001, 86 (5): 1327-30.PubMed Taylor FB, Toh CH, Hoots WK, Wada H, Levi M: Scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and haemostasis (ISTH). towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001, 86 (5): 1327-30.PubMed
4.
go back to reference Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T: FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005, 129 (1): 93-100. 10.1111/j.1365-2141.2005.05420.x.CrossRefPubMed Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T: FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005, 129 (1): 93-100. 10.1111/j.1365-2141.2005.05420.x.CrossRefPubMed
5.
go back to reference Argyle JC, Hogg RJ, Pysher TJ, Silva FG, Siegler RL: A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the southwest pediatric nephrology study group. Pediatr Nephrol. 1990, 4 (1): 52-8. 10.1007/BF00858440.CrossRefPubMed Argyle JC, Hogg RJ, Pysher TJ, Silva FG, Siegler RL: A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the southwest pediatric nephrology study group. Pediatr Nephrol. 1990, 4 (1): 52-8. 10.1007/BF00858440.CrossRefPubMed
6.
go back to reference Barbour T, Johnson S, Cohney S, Hughes P: Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012, 27 (7): 2673-85. 10.1093/ndt/gfs279.CrossRefPubMedPubMedCentral Barbour T, Johnson S, Cohney S, Hughes P: Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012, 27 (7): 2673-85. 10.1093/ndt/gfs279.CrossRefPubMedPubMedCentral
7.
go back to reference Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Ginsburg D, Tsai HM: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001, 413 (6855): 488-94. 10.1038/35097008.CrossRefPubMed Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Ginsburg D, Tsai HM: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001, 413 (6855): 488-94. 10.1038/35097008.CrossRefPubMed
8.
go back to reference Bockmeyer CL, Claus RA, Budde U, Kentouche K, Schneppenheim R, Losche W, Reinhart K, Brunkhorst FM: Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von willebrand factor. Haematologica. 2008, 93 (1): 137-140. 10.3324/haematol.11677.CrossRefPubMed Bockmeyer CL, Claus RA, Budde U, Kentouche K, Schneppenheim R, Losche W, Reinhart K, Brunkhorst FM: Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von willebrand factor. Haematologica. 2008, 93 (1): 137-140. 10.3324/haematol.11677.CrossRefPubMed
9.
go back to reference Douglas KW, Pollock KGJ, Young D, Catlow J, Green R: Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apheresis. 2010, 25 (2): 47-53.PubMed Douglas KW, Pollock KGJ, Young D, Catlow J, Green R: Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apheresis. 2010, 25 (2): 47-53.PubMed
10.
go back to reference Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B: Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU). Intensive Care Med. 2003, 29 (4): 564-569.CrossRefPubMed Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B: Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU). Intensive Care Med. 2003, 29 (4): 564-569.CrossRefPubMed
11.
go back to reference Booth KK, Terrell DR, Vesely SK, George JN: Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011, 86 (9): 743-51. 10.1002/ajh.22091.CrossRefPubMedPubMedCentral Booth KK, Terrell DR, Vesely SK, George JN: Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011, 86 (9): 743-51. 10.1002/ajh.22091.CrossRefPubMedPubMedCentral
12.
go back to reference Wang Z, Yu Z, Su J, Cao L, Zhao X, Ruan C: Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome. Clin Appl Thromb Hemost. 2011, 17 (3): 251-3. 10.1177/1076029609357739.CrossRefPubMed Wang Z, Yu Z, Su J, Cao L, Zhao X, Ruan C: Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome. Clin Appl Thromb Hemost. 2011, 17 (3): 251-3. 10.1177/1076029609357739.CrossRefPubMed
13.
go back to reference Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y: Severe secondary deficiency of von willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006, 107 (2): 528-34. 10.1182/blood-2005-03-1087.CrossRefPubMed Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y: Severe secondary deficiency of von willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006, 107 (2): 528-34. 10.1182/blood-2005-03-1087.CrossRefPubMed
14.
go back to reference Furlan M, Lämmle B: Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von willebrand factor-cleaving protease. Best Pract Res Clin Haematol. 2001, 14 (2): 437-54. 10.1053/beha.2001.0142.CrossRefPubMed Furlan M, Lämmle B: Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von willebrand factor-cleaving protease. Best Pract Res Clin Haematol. 2001, 14 (2): 437-54. 10.1053/beha.2001.0142.CrossRefPubMed
15.
go back to reference Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D: Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest. 2005, 115 (10): 2752-61. 10.1172/JCI26007.CrossRefPubMedPubMedCentral Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D: Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest. 2005, 115 (10): 2752-61. 10.1172/JCI26007.CrossRefPubMedPubMedCentral
16.
go back to reference Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008, 36 (10): 2878-87. 10.1097/CCM.0b013e318186aa49.CrossRefPubMedPubMedCentral Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008, 36 (10): 2878-87. 10.1097/CCM.0b013e318186aa49.CrossRefPubMedPubMedCentral
Metadata
Title
Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation
Authors
Yusuke Sakamaki
Konosuke Konishi
Koichi Hayashi
Akinori Hashiguchi
Matsuhiko Hayashi
Eiji Kubota
Takao Saruta
Hiroshi Itoh
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-260

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.